D. Reilly

Arg16Gly Polymorphism of the β2-adrenergic Receptor Gene Does Not Modulate Clinical Response to Salmeterol in Subjects with Asthma

E. Bleecker, H. Ortega, S. Yancey, 2008 .

Characterization of Asthma Exacerbations by Arg16Gly Genotype in Subjects with Asthma Receiving Salmeterol Alone or with Fluticasone Propionate

E. Bleecker, H. Ortega, S. Yancey, 2008 .

Lack of Effect of Promoter, Coding and 3′ Polymorphisms of the β2-adrenergic Receptor (ADRB2) on the Clinical Response to Salmeterol Alone or with Fluticasone Propionate in Subjects with Asthma

E. Bleecker, H. Ortega, S. Yancey, 2008 .

Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily

L. Edwards, P. Dorinsky, W. Busse, 2003 .

Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.

L. Edwards, P. Dorinsky, W. Busse, 2003, The Journal of allergy and clinical immunology.

Salmeterol plus theophylline combination therapy in the treatment of COPD.

R. Zuwallack, D. Mahler, A. Emmett, 2001, Chest.

Long-term effectiveness of the fluticasone propionate/salmeterol (FSC) 100/50 mcg combination product as an inhaled corticosteroid sparing agent*

P. Dorinsky, S. Yancey, L. L. Edwards, 2003 .

Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.

L. Edwards, P. Dorinsky, S. Yancey, 2006, The Journal of allergy and clinical immunology.

Increased taste thresholds of amino acids with age.

S. Schiffman, D. Reilly, K. Hornack, 1979, The American journal of clinical nutrition.

Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.

S. Kreitzer, E. Ståhl, P. Chervinsky, 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Montelukast added to fluticasone propionate does not alter inflammation or outcomes.

L. Edwards, P. Dorinsky, E. Bleecker, 2010, Respiratory medicine.